Literature DB >> 1703353

Use of FK 506 in pediatric patients.

A G Tzakis1, J J Fung, S Todo, J Reyes, M Green, T E Starzl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1703353      PMCID: PMC3003928     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  19 in total

1.  The side effects of FK 506 in humans.

Authors:  R Shapiro; J J Fung; A B Jain; P Parks; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

2.  FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood.

Authors:  J McCauley; A G Tzakis; J J Fung; S Todo; T E Starzl
Journal:  Lancet       Date:  1990-03-17       Impact factor: 79.321

3.  A clinical trial of FK 506 as primary and rescue immunosuppression in cardiac transplantation.

Authors:  J M Armitage; R L Kormos; B P Griffith; R L Hardesty; F J Fricker; R S Stuart; G C Marrone; S Todo; J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

4.  Human islet isolation and purification from pediatric-age donors.

Authors:  C Ricordi; R Alejandro; Y Zeng; A Tzakis; A Casavilla; R Jaffe; D H Mintz; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

5.  Transplantation.

Authors:  T E Starzl; J J Fung
Journal:  JAMA       Date:  1990-05-16       Impact factor: 56.272

6.  Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies.

Authors:  T E Starzl; S Todo; A Tzakis; L Podesta; L Mieles; A Demetris; L Teperman; R Selby; W Stevenson; A Stieber
Journal:  Ann Surg       Date:  1989-09       Impact factor: 12.969

7.  FK 506 for liver, kidney, and pancreas transplantation.

Authors:  T E Starzl; S Todo; J Fung; A J Demetris; R Venkataramman; A Jain
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

8.  Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.

Authors:  G L Davis; L A Balart; E R Schiff; K Lindsay; H C Bodenheimer; R P Perrillo; W Carey; I M Jacobson; J Payne; J L Dienstag
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

9.  Liver, kidney, and thoracic organ transplantation under FK 506.

Authors:  S Todo; J J Fung; T E Starzl; A Tzakis; A J Demetris; R Kormos; A Jain; M Alessiani; S Takaya; R Shapiro
Journal:  Ann Surg       Date:  1990-09       Impact factor: 12.969

10.  Pancreatic islet transplantation after upper abdominal exenteration and liver replacement.

Authors:  A G Tzakis; C Ricordi; R Alejandro; Y Zeng; J J Fung; S Todo; A J Demetris; D H Mintz; T E Starzl
Journal:  Lancet       Date:  1990-08-18       Impact factor: 79.321

View more
  14 in total

1.  Pediatric liver transplantation in 808 consecutive children: 20-years experience from a single center.

Authors:  A Jain; G Mazariegos; R Kashyap; B Kosmach-Park; T E Starzl; J J Fung; J Reyes
Journal:  Transplant Proc       Date:  2002-08       Impact factor: 1.066

2.  Graft-versus-host disease following liver transplantation.

Authors:  N D Heaton; A S Reece; K C Tan
Journal:  J R Soc Med       Date:  1992-06       Impact factor: 5.344

3.  FK 506 versus cyclosporine in pediatric liver transplantation.

Authors:  A G Tzakis; J Reyes; S Todo; M Green; T Ohya; A Jain; K Abu-Elmagd; M Alessiani; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

4.  Neurologic complications of FK 506.

Authors:  B H Eidelman; K Abu-Elmagd; J Wilson; J J Fung; M Alessiani; A Jain; S Takaya; S N Todo; A Tzakis; D Van Thiel
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

5.  Infectious complications of pediatric liver transplantation under FK 506.

Authors:  M Green; A Tzakis; J Reyes; B Nour; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

6.  Use of FK 506 in pediatric patients.

Authors:  A G Tzakis; J J Fung; S Todo; J Reyes; M Green; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

7.  Two-year experience with FK 506 in pediatric patients.

Authors:  A G Tzakis; J Reyes; S Todo; B Nour; R Shapiro; M Jordan; J McCauley; J Armitage; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

Review 8.  Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

9.  A long-term experience with biliary atresia. Reassessment of prognostic factors.

Authors:  D U Tagge; E P Tagge; R A Drongowski; K T Oldham; A G Coran
Journal:  Ann Surg       Date:  1991-11       Impact factor: 12.969

Review 10.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.